{
"@context": "https://schema.org",
"@type": "Article",
"headline": "The Outcome of the EC Pharmaceutical Sector Inquiry",
"url": "https://www.lexblog.com/2009/09/03/the-outcome-of-the-ec-pharmaceutical-sector-inquiry/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-SPX4SXTN",
"url": "https://www.lexblog.com/lib/SPX4SXTN/"
},
"datePublished": "2009-09-03T06:21:26-04:00",
"dateModified": "2021-06-22T11:57:16-04:00",
"author": {
"@type": "Person",
"name": "Inside EU Life Sciences"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Covington & Burling LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Inside EU Life Sciences",
"about": "Antitrust, Competition and Trade ยท Health Care and Life Sciences",
"sourceUrl": "http://insideeulifesciences.default.wp1.lexblog.com/?p=528",
"sourceStability": "may-move"
}